The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · Real-Time Price · USD
3.440
+0.110 (3.30%)
At close: Apr 28, 2026, 4:00 PM EDT
3.365
-0.075 (-2.18%)
Pre-market: Apr 29, 2026, 6:00 AM EDT
The Oncology Institute Revenue
In the year 2025, The Oncology Institute had annual revenue of $502.73M with 27.79% growth. The Oncology Institute had revenue of $141.96M in the quarter ending December 31, 2025, with 41.58% growth.
Revenue (ttm)
$502.73M
Revenue Growth
+27.79%
P/S Ratio
0.68
Revenue / Employee
$784,289
Employees
641
Market Cap
340.01M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Community Health Systems | 12.29B |
| agilon health | 5.93B |
| AMN Healthcare Services | 2.73B |
| Auna S.A. | 1.30B |
| Enhabit | 1.06B |
| Cross Country Healthcare | 1.05B |
| Nutex Health | 875.26M |
| Strata Critical Medical | 197.14M |
TOI News
- 1 day ago - The Oncology Institute Announces First Quarter 2026 Earnings Release Date and Conference Call - GlobeNewsWire
- 6 weeks ago - The Oncology Institute Reports Fourth Quarter and Full Year 2025 Financial Results and Guidance for 2026 - GlobeNewsWire
- 3 months ago - U.S. Neurology Associates Partners with M33 Growth to Transform Neurological Care - GlobeNewsWire
- 3 months ago - The Oncology Institute Announces Leadership Promotions - GlobeNewsWire
- 5 months ago - The Oncology Institute Announces Resignation of Board Member Gabe Ling - GlobeNewsWire
- 5 months ago - Ascertain and The Oncology Institute Co-Develop ‘Touchless' AI Automation for Oncology Administration - GlobeNewsWire
- 6 months ago - The Oncology Institute Announces Third Quarter 2025 Earnings Release Date and Conference Call - GlobeNewsWire
- 8 months ago - The Oncology Institute Launches Lung Cancer Center of Excellence in Florida Led by International Oncology Expert Dr. Edgardo Santos - GlobeNewsWire